Literature DB >> 11238956

A novel mitogen-activated protein kinase is responsive to Raf and mediates growth factor specificity.

M Janulis1, N Trakul, G Greene, E M Schaefer, J D Lee, M R Rosner.   

Abstract

The proto-oncogene Raf is a major regulator of growth and differentiation. Previous studies from a number of laboratories indicate that Raf activates a signaling pathway that is independent of the classic MEK1,2-ERK1,2 cascade. However, no other signaling cascade downstream of Raf has been identified. We describe a new member of the mitogen-activated protein kinase family, p97, an ERK5-related kinase that is activated and Raf associated when cells are stimulated by Raf. Furthermore, p97 is selectively responsive to different growth factors, providing a mechanism for specificity in cellular signaling. Thus, p97 is activated by the neurogenic factor fibroblast growth factor (FGF) but not the mitogenic factor epidermal growth factor (EGF) in neuronal cells. Conversely, the related kinase ERK5 is activated by EGF but not FGF. p97 phosphorylates transcription factors such as Elk-1 and Ets-2 but not MEF2C at transactivating sites, whereas ERK5 phosphorylates MEF2C but not Elk-1 or Ets-2. Finally, p97 is expressed in a number of cell types including primary neural and NIH 3T3 cells. Taken together, these results identify a new signaling pathway that is distinct from the classic Raf-MEK1,2-ERK1,2 kinase cascade and can be selectively stimulated by growth factors that produce discrete biological outcomes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238956      PMCID: PMC86857          DOI: 10.1128/MCB.21.6.2235-2247.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

1.  Preserved acute pain and reduced neuropathic pain in mice lacking PKCgamma.

Authors:  A B Malmberg; C Chen; S Tonegawa; A I Basbaum
Journal:  Science       Date:  1997-10-10       Impact factor: 47.728

2.  14-3-3 proteins are required for maintenance of Raf-1 phosphorylation and kinase activity.

Authors:  J A Thorson; L W Yu; A L Hsu; N Y Shih; P R Graves; J W Tanner; P M Allen; H Piwnica-Worms; A S Shaw
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

Review 3.  Signaling through scaffold, anchoring, and adaptor proteins.

Authors:  T Pawson; J D Scott
Journal:  Science       Date:  1997-12-19       Impact factor: 47.728

4.  Raf and fibroblast growth factor phosphorylate Elk1 and activate the serum response element of the immediate early gene pip92 by mitogen-activated protein kinase-independent as well as -dependent signaling pathways.

Authors:  K C Chung; I Gomes; D Wang; L F Lau; M R Rosner
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

Review 5.  Signal transduction through MAP kinase cascades.

Authors:  T S Lewis; P S Shapiro; N G Ahn
Journal:  Adv Cancer Res       Date:  1998       Impact factor: 6.242

6.  Osmotic activation of the HOG MAPK pathway via Ste11p MAPKKK: scaffold role of Pbs2p MAPKK.

Authors:  F Posas; H Saito
Journal:  Science       Date:  1997-06-13       Impact factor: 47.728

7.  Differentiation of central nervous system neuronal cells by fibroblast-derived growth factor requires at least two signaling pathways: roles for Ras and Src.

Authors:  W L Kuo; K C Chung; M R Rosner
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

8.  BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C.

Authors:  Y Kato; V V Kravchenko; R I Tapping; J Han; R J Ulevitch; J D Lee
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

9.  Persistent activation of mitogen-activated protein kinases p42 and p44 and ets-2 phosphorylation in response to colony-stimulating factor 1/c-fms signaling.

Authors:  L F Fowles; M L Martin; L Nelsen; K J Stacey; D Redd; Y M Clark; Y Nagamine; M McMahon; D A Hume; M C Ostrowski
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

10.  A role for RalGDS and a novel Ras effector in the Ras-mediated inhibition of skeletal myogenesis.

Authors:  M B Ramocki; M A White; S F Konieczny; E J Taparowsky
Journal:  J Biol Chem       Date:  1998-07-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.